HC Group Issues Quarterly Resumption Progress Update; Trading to Stay Suspended

Bulletin Express
09/30

HC Group Inc. released a quarterly update on 30 September 2026 outlining its progress toward meeting the Hong Kong Stock Exchange’s (HKEX) resumption requirements. Trading in HC Group shares has been halted since 18 March 2026 and will remain suspended until all six items of HKEX Resumption Guidance are fulfilled. Key developments are as follows:

1. Forensic investigation. An Investigation Committee formed on 8 July 2026 has appointed GT Advisory to conduct an independent forensic review of disputed prepayments. HC Group will publish the findings once available.

2. Outstanding financial statements. External auditor Rongcheng is finalising the audit of FY 2025 results and preparing the 2026 interim figures. Based on current procedures and a draft forensic report, Rongcheng does not expect the prepayment issue to affect its audit opinion but will complete further work on subsequent events, going-concern assessment and internal control findings before issuing the final report.

3. Management integrity review. The Investigation Committee will evaluate directors and senior executives after the forensic report is completed to address HKEX concerns over management competence and integrity.

4. Internal control overhaul. GT Advisory has also been engaged to perform an independent internal control review. HC Group intends to disclose key findings and remedial measures in due course.

5. Business operations. Despite the trading halt, the Group reports normal operations. Revenue continues to stem from two core divisions: (i) technology-driven new retail, focused on online advertising and platform services for 3C digital products, and (ii) smart industries, covering product digital identity solutions, IoT offerings, SaaS products and integrated supply-chain services. Management expects both segments to maintain broadly stable scale and performance versus prior-year comparables.

6. Ongoing disclosure. The company pledges timely announcements to keep investors informed of material developments and the status of resumption efforts.

No timetable for trading resumption has been provided. Investors are advised to exercise caution while HC Group completes the forensic investigation, finalises audited results and rectifies internal control deficiencies required by HKEX.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10